Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025International Journal of Molecular SciencesOpen Access

The Role of ADAM9 and MMP9 in Diabetic Retinopathy: Insights from Ocular Parameters

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMehmet Ali GülDTDuygu TozcuNANihat Aydın

Discussion

Loading...

Member takes

Overview

Study evaluates ADAM9 and MMP9 levels in diabetic retinopathy patients, suggesting potential therapeutic targets.

Key Points

  • ADAM9 and MMP9 levels differ significantly between diabetic retinopathy patients and healthy controls.
  • Serum ADAM9 was significantly lower in both NPDR and PDR groups compared to controls, highlighting its potential role.
  • MMP9 levels fluctuated notably in the PDR group, indicating its specific role in retinopathy progression.
  • This study suggests that monitoring ADAM9 and MMP9 could aid in assessing the severity of diabetic retinopathy.

Cite This Study

Gül et al. (2025) studied this question.

synapsesocial.com/papers/68c1d80554b1d3bfb60fa852https://doi.org/10.3390/ijms26178436
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure, regulatory factors and cancer-related physiological effects of ADAM92020 · 14 citations
  2. 2Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy2021 · 21 citations
  3. 3The involvement of ACO3 protein in diabetic retinopathy through the PI3k/Akt signaling pathway2022 · 7 citations
  4. 4Link Between Metabolic Syndrome, Inflammation, and Eye Diseases2025 · 23 citations
  5. 5Role of lymphotoxin alpha as a new molecular biomarker in revolutionizing tear diagnostic testing for dry eye disease2023 · 8 citations